Meeting
2024 ASCO Annual Meeting
Survival and mutational differences based on ESR1 and ESR2 expression in non-small cell lung cancer (NSCLC).
Authors
Robert Hsu
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
Robert Hsu , Alexis Leyba , Denaly Chen , Harris Benjamin Krause , Andrew Elliott , Wendy Cozen , Evanthia T. Roussos Torres , Misako Nagasaka , Hirva Mamdani , Gilberto Lopes , Hossein Borghaei , Stephen V. Liu , Patrick C. Ma , Ari M. Vanderwalde , Jorge J. Nieva
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 8526)
DOI
10.1200/JCO.2024.42.16_suppl.8526
Abstract #
8526
Poster Bd #
390
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical, pathologic, and genomic hallmarks of KRAS-amplified non-small cell lung cancer.
First Author: Biagio Ricciuti
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
First Author: Heng Tan
Poster
2019 ASCO Annual Meeting
Clonal evolution and osimertinib resistance mechanisms identified by whole exome and transcriptome sequencing in EGFR mutant NSCLC.
First Author: Nitin Roper
Poster
2023 ASCO Quality Care Symposium
Stepwise prolongation of overall survival from first- to third-generation EGFR-tyrosine kinase inhibitors in non-small cell lung cancer and the prognostic impact of concomitant antacids.
First Author: Kiyoaki Uryu